Melphalan intra-arterial chemotherapy for choroidal melanoma chemoreduction (2022)
Source: International Journal of Retina and Vitreous. Unidade: FMRP
Subjects: MELANOMA, ÚVEA, QUIMIOTERAPIA, ANTINEOPLÁSICOS, RUTÊNIO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
JORGE, Rodrigo et al. Melphalan intra-arterial chemotherapy for choroidal melanoma chemoreduction. International Journal of Retina and Vitreous, v. 8, p. 1-5, 2022Tradução . . Disponível em: https://doi.org/10.1186/s40942-022-00404-1. Acesso em: 27 jan. 2026.APA
Jorge, R., Coelho, I. N., Arruda, G. V., Vieira, A. A. R., Chahud, F., Abud, D. G., & Correa, Z. M. (2022). Melphalan intra-arterial chemotherapy for choroidal melanoma chemoreduction. International Journal of Retina and Vitreous, 8, 1-5. doi:10.1186/s40942-022-00404-1NLM
Jorge R, Coelho IN, Arruda GV, Vieira AAR, Chahud F, Abud DG, Correa ZM. Melphalan intra-arterial chemotherapy for choroidal melanoma chemoreduction [Internet]. International Journal of Retina and Vitreous. 2022 ; 8 1-5.[citado 2026 jan. 27 ] Available from: https://doi.org/10.1186/s40942-022-00404-1Vancouver
Jorge R, Coelho IN, Arruda GV, Vieira AAR, Chahud F, Abud DG, Correa ZM. Melphalan intra-arterial chemotherapy for choroidal melanoma chemoreduction [Internet]. International Journal of Retina and Vitreous. 2022 ; 8 1-5.[citado 2026 jan. 27 ] Available from: https://doi.org/10.1186/s40942-022-00404-1
